Skip to content

LENSAR Receives EU Certification for ALLY Adaptive Cataract Treatment System

๐‹๐„๐๐’๐€๐‘ ๐‘๐ž๐œ๐ž๐ข๐ฏ๐ž๐ฌ ๐„๐” ๐‚๐ž๐ซ๐ญ๐ข๐Ÿ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐…๐จ๐ซ ๐€๐‹๐‹๐˜ ๐€๐๐š๐ฉ๐ญ๐ข๐ฏ๐ž ๐‚๐š๐ญ๐š๐ซ๐š๐œ๐ญ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ
๐Ÿ‘ฉโ€โš•๏ธ LENSAR, Inc. has received EU certification for its ALLY adaptive cataract treatment system, marking a significant milestone in ophthalmic surgery. The ALLY system integrates femtosecond laser and phacoemulsification technologies into a single platform, enhancing the precision and efficiency of cataract procedures.

๐Ÿ‘ This certification allows LENSAR to market and distribute the ALLY system throughout the European Union, offering surgeons advanced tools for improved patient outcomes. The approval is a crucial step in expanding the availability of innovative cataract surgery solutions worldwide.